A recent report from Pfister and co-workers [41] sheds some light on these inconsistencies by showing that depleting CD8+ T-cells following the onset of NASH, but prior to HCC development, effectively reduces HCC incidence in mice. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.